Medications for Thyroid Carcinoma

5 results
  • gavreto - pralsetinib capsule

    (Pralsetinib)
    Genentech, Inc.
    GAVRETO is a kinase inhibitor for adults with metastatic RET fusion-positive non-small cell lung cancer, and for adults and patients 12+ with advanced or metastatic RET fusion-positive thyroid cancer requiring systemic therapy who are radioactive iodine-refractory.
  • retevmo - selpercatinib capsule

    (Selpercatinib)
    Eli Lilly And Company
    Retevmo treats adults with RET fusion-positive locally advanced or metastatic non-small cell lung cancer. It also treats adults and children (≥2 years) with RET-mutant or RET fusion-positive advanced thyroid cancers requiring systemic therapy, and RET fusion-positive solid tumors that progressed on prior treatment.
  • synthroid - levothyroxine sodium tablet

    (Levothyroxine Sodium)
    Abbvie Inc.
    SYNTHROID treats primary, secondary, and tertiary hypothyroidism in adults and children, including neonates, as replacement therapy. Also used with surgery and radioiodine therapy to manage thyrotropin-dependent well-differentiated thyroid cancer.
  • tirosint - levothyroxine sodium capsule

    (Levothyroxine Sodium)
    Ibsa Pharma Inc.
    Tirosint (L-thyroxine/T4) treats hypothyroidism as replacement therapy in adults and children 6+ with primary, secondary, or tertiary congenital or acquired hypothyroidism. Also used adjunctively with surgery and radioiodine therapy to suppress TSH in thyrotropin-dependent well-differentiated thyroid cancer.
  • tirosint sol - levothyroxine sodium solution

    (Levothyroxine Sodium)
    Ibsa Pharma Inc.
    Tirosint (levothyroxine T4) treats hypothyroidism — primary, secondary, and tertiary — in adults, children, and neonates. Also used alongside surgery and radioiodine therapy to suppress TSH in well-differentiated thyroid cancer.